Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PBC Prospect Capital Corp

退市 11-06 04:00:29 EST

25.06

+0.00

0.00%

最高25.06	最低25.06	成交量0.00
今开25.06	昨收25.06	日振幅0.00%
总市值92.18亿	流通市值0.00	总股本3.68亿
成交额31.97万	换手率--	流通股本0.00
市净率2.90	ROE4.16%	每股收益0.37
52周最高26.49	52周最低25.00	市盈率68.17
股息0.72	股息收益率0.03	ROA4.83%

北京优虎网络科技有限公司

{"stockData":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"退市","change":0,"latestTime":"11-06 04:00:23 EST","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762439400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"requestUrl":"/m/hq/s/PBC","defaultTab":"news","newsList":[{"id":"2581777998","title":"（第八届进博会）跨国药企深耕进博会 加速创新成果落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2581777998","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581777998?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:40","pubTimestamp":1762353653,"startTime":"0","endTime":"0","summary":"中新社上海11月5日电(记者陈静)“过去七年，从展品到商品，再到临床广泛可及，进博会已成为创新药物加速惠及中国患者的重要催化平台。”诺华公司中国区副总裁，心血管、肾脏及代谢治疗领域兼创新患者服务负责人管宏5日对记者表示，得益于进博会的溢出效应，诺华公司多款心肾领域的创新药物实现首秀到落地的跨越。第八届中国国际进口博览会5日开幕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053556163538.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053556163538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0823416689.USD","BK4585","IE0002270589.USD","SG9999015978.USD","IE00BZ1G4Q59.USD","PBC","BK4566","LU1430594728.SGD","BK4532","06978","BK1161","LU0289739699.SGD","BK4578","LU2468319806.SGD","SG9999015945.SGD","BK4568","BK4583","LU0109394709.USD","LU0234570918.USD","LU2087621335.USD","IE00B3T34201.USD","SG9999015986.USD","LU0889565916.HKD","SG9999015952.SGD","LU0882574055.USD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU1585245621.USD","BK1574","LU1066051498.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1839511570.USD","BK4550","LU1778281490.HKD","GILD","LU0058720904.USD","LU0114720955.EUR","LU1066053197.SGD","LU1571399168.USD","IE00BSNM7G36.USD","BK4588","LU1674673691.USD","LU2089984988.USD","BK4139","LU2324357040.USD","LU0320765992.SGD","LU1674673428.USD"],"gpt_icon":0},{"id":"2581720929","title":"进博观察：开放平台引“凤”来，医疗药械焕新健康动能","url":"https://stock-news.laohu8.com/highlight/detail?id=2581720929","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581720929?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:31","pubTimestamp":1762345866,"startTime":"0","endTime":"0","summary":"11月5日，第八届中国国际进口博览会（下称“进博会”）在上海盛大开幕。本届进博会吸引155个国家、地区和国际组织赴约，4108家境外企业带来最新成果，43万平方米展馆汇聚全球智慧，进博规模再创新高。自2018年首届以来，进博会已逐步强化国际采购、投资促进、人文交流、开放合作“四大平台”功能，成为全球瞩目的开放合作盛会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053556078911.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053556078911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PBC"],"gpt_icon":0},{"id":"2581715385","title":"吉利德四赴进博会：全球首款长效HIV预防药亚洲首秀","url":"https://stock-news.laohu8.com/highlight/detail?id=2581715385","media":"南方都市报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581715385?lang=zh_cn&edition=full","pubTime":"2025-11-04 13:24","pubTimestamp":1762233852,"startTime":"0","endTime":"0","summary":"从“展品”到“药品”，从“首展”到“首用”，吉利德科学借进博会“黄金跑道”持续跑出“中国速度”。11月展台现场，吉利德将首次在亚洲公开展示这一全新的HIV预防方案，并同步披露其在全球同步研发框架下中国参与项目的最新进展——10项肿瘤、6项非肿瘤研究中，90%的肿瘤项目已实现与全球“零时差”开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104132704a6df8bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104132704a6df8bb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU1571399168.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU2089984988.USD","LU0289739699.SGD","BK4588","LU1674673428.USD","LU0058720904.USD","SG9999015986.USD","BK4578","LU2087621335.USD","BK4568","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","GILD","LU1430594728.SGD","BK4583","LU1585245621.USD","LU1674673691.USD","BK4550","LU0114720955.EUR","LU1066051498.USD","LU1839511570.USD","LU0234570918.USD","LU0882574055.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU1066053197.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","BK4585","SG9999015978.USD","BK4566","IE0002270589.USD","BK4139","LU2468319806.SGD","LU2324357040.USD","SG9999015945.SGD","SG9999015952.SGD","LU0823416689.USD","BK4532","LU0889565916.HKD","PBC","LU1778281490.HKD"],"gpt_icon":0},{"id":"2579996194","title":"刚刚！利好突袭 直线爆拉！","url":"https://stock-news.laohu8.com/highlight/detail?id=2579996194","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579996194?lang=zh_cn&edition=full","pubTime":"2025-10-28 23:39","pubTimestamp":1761665940,"startTime":"0","endTime":"0","summary":"OpenAI宣布已完成资本重组，确立其组织架构为：由非营利机构对其营利性业务持有控股权。这家人工智能初创公司表示，其非营利机构现更名为OpenAI基金会，并持有营利性部门约1300亿美元的股权。OpenAI称，其营利性部门现为一家公益性公司，名为OpenAI Group PBC。受消息影响，微软股价在盘前一度直线拉升，暴涨超5%；正式开盘之后，涨幅有所回落，总市值再度站上4万亿美元大关。收入分成协议将持续至独立专家小组核验AGI，但付款周期将拉长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510282348359746f3ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510282348359746f3ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z8X17.USD","LU2360106780.USD","LU1481600234.SGD","PBC","LU2023250504.SGD","AGI","BK4504","IE00BJTD4N35.SGD","LU2360108059.USD","LU0234570918.USD","LU2506951875.HKD","LU0708994859.HKD","LU1674673428.USD","SG9999014880.SGD","BK4532","LU0640476718.USD","IE00B7KXQ091.USD","LU0426417589.USD","LU2506952097.USD","SG9999018857.SGD","LU2023251221.USD","MSFT","LU2191332357.HKD","LU0390134368.USD","LU2756315664.SGD","SG9999014575.USD","LU2860962120.EUR","LU1935043536.SGD","LU2420271590.USD","IP","LU2286300806.USD","LU0889566641.SGD","LU0011850046.USD","SG9999014914.USD","LU2456880835.USD","LU2756315318.SGD","LU1674673691.USD","LU1564329461.SGD","IE00B4JS1V06.HKD","LU0353189763.USD","IE00B3S45H60.SGD","LU1564329115.USD","LU1989764748.USD","LU1815336760.USD","LU0316494557.USD","LU1989764664.SGD","LU1935043023.USD","LU2463028550.USD","LU2506952170.USD","LU0661504455.SGD"],"gpt_icon":1},{"id":"2577307068","title":"跨国药企高层：进博会强大“溢出效应”成全球创新成果落地“加速器”","url":"https://stock-news.laohu8.com/highlight/detail?id=2577307068","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577307068?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:06","pubTimestamp":1761224803,"startTime":"0","endTime":"0","summary":"中新网上海10月23日电(记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510233542559744.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510233542559744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0889565916.HKD","BK4550","BK4585","IE00BSNM7G36.USD","LU1066053197.SGD","LU0289739699.SGD","LU0058720904.USD","LU0823416689.USD","GILD","IE00B19Z3581.USD","PBC","LU1066051498.USD","LU2324357040.USD","BK4583","LU0234570918.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","SG9999015986.USD","SG9999015945.SGD","SG9999015978.USD","LU0320765992.SGD","BK4578","LU1585245621.USD","BK4588","LU2087621335.USD","LU0109394709.USD","BK4139","IE00B7SZLL34.SGD","LU1839511570.USD","IE00BKVL7J92.USD","BK4532","LU1674673691.USD","LU2089984988.USD","BK4566","BK4568","LU1778281490.HKD","LU1430594728.SGD","LU0882574055.USD","LU2468319806.SGD","IE0002270589.USD","IE00B3T34201.USD","SG9999015952.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU1674673428.USD"],"gpt_icon":0},{"id":"2577306333","title":"吉利德13款新药加速惠及中国患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2577306333","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577306333?lang=zh_cn&edition=full","pubTime":"2025-10-23 19:16","pubTimestamp":1761218177,"startTime":"0","endTime":"0","summary":"第八届中国国际进口博览会将于11月5日在上海开幕，吉利德科学将第四次亮相这一盛会。吉利德科学全球副总裁、中国区总经理金方千表示：“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的溢出效应，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510233542486544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","06978","PBC"],"gpt_icon":0},{"id":"2577387943","title":"Tharimmune, Inc.盘中异动 股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577387943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577387943?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:59","pubTimestamp":1761055143,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时59分，Tharimmune, Inc.股票出现异动，股价快速下挫5.38%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1205.30%、166.31%、49.04%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、78.99%、47.03%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102121590394d5f53d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102121590394d5f53d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"gpt_icon":0},{"id":"2575477592","title":"Tharimmune, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575477592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575477592?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:04","pubTimestamp":1760461453,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日01时04分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.04%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Senti Biosciences, Inc.涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2802.30%、38.15%、37.55%，振幅较大的相关个股有Pmgc Holdings Inc.、Cdt Equity Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为55.85%、38.33%、37.50%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501041394c91e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501041394c91e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"gpt_icon":0},{"id":"2574432962","title":"Tharimmune, Inc.盘中异动 早盘急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574432962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574432962?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:39","pubTimestamp":1760107161,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时39分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.38%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Gyre Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Q32 Bio Inc.涨幅较大，Aditxt, Inc.、Cdt Equity Inc.、Intensity Therapeutics, Inc.较为活跃，换手率分别为321.98%、70.15%、49.71%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Briacell Therapeutics Corp C/Wts 26/02/2026、知临集团，振幅分别为39.68%、33.20%、29.54%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022392194c204ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022392194c204ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"gpt_icon":0},{"id":"2566914287","title":"OpenAI：非营利性母公司将持有超1000亿美元的公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2566914287","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566914287?lang=zh_cn&edition=full","pubTime":"2025-09-12 05:36","pubTimestamp":1757626592,"startTime":"0","endTime":"0","summary":"OpenAI周四表示，其非营利母公司将继续监督该公司，并将持有超过1000亿美元的股权。\n　　这家最近估值5000亿美元的人工智能初创公司表示，这种结构将使这家非营利组织成为“世界上资源最充足的慈善组织之一”，并将使该公司能够继续筹集资金。\n　　OpenAI董事长Bret Taylor在一份声明中写道：“这种结构重申了我们的核心使命仍然是确保AGI造福全人类。我们的公益企业（PBC）章程和治理机制将明确，安全决策必须始终以这一使命为导向。”\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：李桐","market":"us","thumbnail":"http://n.sinaimg.cn/finance/transform/54/w550h304/20250912/62a4-6ba79671ada4e9e12f989134dfa7b24a.png","type":0,"news_type":0,"thumbnails":["http://n.sinaimg.cn/finance/transform/54/w550h304/20250912/62a4-6ba79671ada4e9e12f989134dfa7b24a.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-09-12/doc-infqerfv3160215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["PBC"],"gpt_icon":0},{"id":"2565734638","title":"美股异动 | 上调2026财年营收预期 Planet Labs PBC(PL.US)飙升超36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565734638","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565734638?lang=zh_cn&edition=full","pubTime":"2025-09-08 23:39","pubTimestamp":1757345954,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，Planet Labs PBC(PL.US)飙升超36%，创三年半新高，报8.91美元。消息面上，该公司第二财季营收同比增长20%，达到创纪录的7340万美元，是分析师预期的两倍。同时Planet Labs PBC还上调26财年营收预期至2.81亿美元-2.89亿美元，高于其6月份给出的2.65亿-2.8亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PL","PBC"],"gpt_icon":0},{"id":"2565968259","title":"Planet Labs PBC美股盘初大涨超18%其第二财季营收同比增长20%达到创纪录的7340万美元是分析师预期的两","url":"https://stock-news.laohu8.com/highlight/detail?id=2565968259","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565968259?lang=zh_cn&edition=full","pubTime":"2025-09-08 21:30","pubTimestamp":1757338241,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"81cab41ca1bc9f2e09285664a7ec2f36","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PBC"],"gpt_icon":0},{"id":"2562171597","title":"歌礼制药-B盘中异动 下午盘股价大跌5.06%报13.320港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562171597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562171597?lang=zh_cn&edition=full","pubTime":"2025-08-27 15:05","pubTimestamp":1756278346,"startTime":"0","endTime":"0","summary":"2025年08月27日下午盘15时05分，歌礼制药-B股票出现异动，股价快速跳水5.06%。截至发稿，该股报13.320港元/股，成交量452.312万股，换手率0.46%，振幅9.55%。资金方面，该股资金流入1740.38万港元，流出4017.87万港元。歌礼制药-B股票所在的生物技术行业中，整体跌幅为5.07%。其相关个股中，贝康医疗-B、中生北控生物科技、东曜药业-B涨幅较大，振幅较大的相关个股有三叶草生物-B、康诺亚-B、基石药业-B，振幅分别为19.57%、16.08%、15.22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082715054694ffe114&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082715054694ffe114&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC"],"gpt_icon":0},{"id":"2561282952","title":"Tharimmune, Inc.盘中异动 早盘快速下跌10.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561282952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561282952?lang=zh_cn&edition=full","pubTime":"2025-08-22 21:31","pubTimestamp":1755869490,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日21时31分，Tharimmune, Inc.股票出现波动，股价快速跳水10.13%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Liminatus Pharma, Inc.、Pmgc Holdings Inc.涨幅较大，Pmgc Holdings Inc.、Azitra Inc、Genprex, Inc.较为活跃，换手率分别为1688.36%、342.11%、191.43%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Ethzilla Corporation C/Wts 06/11/2025、Pmgc Holdings Inc.，振幅分别为130.14%、11.21%、9.52%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822213130a6f5a356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822213130a6f5a356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC"],"gpt_icon":0},{"id":"2560304161","title":"歌礼制药-B盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560304161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560304161?lang=zh_cn&edition=full","pubTime":"2025-08-18 10:35","pubTimestamp":1755484555,"startTime":"0","endTime":"0","summary":"2025年08月18日早盘10时35分，歌礼制药-B股票出现波动，股价急速拉升5.07%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为0.33%。消息层面，截至10时35分，《歌礼制药-B发布中期业绩，股东应占亏损8795.1万元 同比收窄32.5%》资讯为影响歌礼制药-B的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818103555974e2464&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818103555974e2464&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC"],"gpt_icon":0},{"id":"2558624206","title":"Tharimmune, Inc.盘中异动 快速上涨5.32%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558624206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558624206?lang=zh_cn&edition=full","pubTime":"2025-08-12 02:10","pubTimestamp":1754935817,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日02时10分，Tharimmune, Inc.股票出现异动，股价快速上涨5.32%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Equillium, Inc.、Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6092.92%、628.08%、438.04%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"gpt_icon":0},{"id":"2557456198","title":"Tharimmune, Inc.盘中异动 股价大涨9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557456198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557456198?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:55","pubTimestamp":1754574941,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时55分，Tharimmune, Inc.股票出现波动，股价大幅拉升9.09%。截至发稿，该股报1.32美元/股，成交量809股，换手率0.02%，振幅0.00%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807215541a6d90336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807215541a6d90336&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"gpt_icon":0},{"id":"2556804163","title":"泰尔西咨询集团分析师萨朗・沃拉将Zevia PBC A 类股的评级从 “与大盘持平” 上调至 “跑赢大盘”。目标价定为","url":"https://stock-news.laohu8.com/highlight/detail?id=2556804163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556804163?lang=zh_cn&edition=full","pubTime":"2025-08-04 17:12","pubTimestamp":1754298724,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ZVIA","BK4539","BK4177","PBC"],"gpt_icon":0},{"id":"2556885848","title":"Tharimmune, Inc.盘中异动 下午盘股价大跌5.30%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556885848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556885848?lang=zh_cn&edition=full","pubTime":"2025-08-01 02:50","pubTimestamp":1753987855,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日02时50分，Tharimmune, Inc.股票出现异动，股价大幅跳水5.30%。截至发稿，该股报1.25美元/股，成交量9437股，换手率0.22%，振幅3.80%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.73%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801025055a6cc25ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801025055a6cc25ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"gpt_icon":0},{"id":"2552826824","title":"Tharimmune, Inc.盘中异动 股价大涨6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552826824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552826824?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:46","pubTimestamp":1752759993,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时46分，Tharimmune, Inc.股票出现波动，股价大幅上涨6.86%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Immuron Limited、Abpro Holdings, Inc较为活跃，换手率分别为655.67%、180.21%、107.81%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为56.67%、54.76%、50.00%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214633a6affd4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214633a6affd4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prospectstreet.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":0.0089},{"period":"3month","weight":0.0717},{"period":"6month","weight":0.2007},{"period":"1year","weight":0.1749},{"period":"ytd","weight":0.1561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prospect Capital Corporation成立于2004年4月13日，是一家封闭式投资公司。公司是一家金融服务公司，主要向中等市场的私人控股公司提供贷款和投资。公司是一家在马里兰州注册成立的封闭式投资公司。其投资目标是通过债务和股权投资实现当期收益和长期资本增值。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.034529},{"month":2,"riseRate":0,"avgChangeRate":-0.031267},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.060348},{"month":4,"riseRate":1,"avgChangeRate":0.067548},{"month":5,"riseRate":0.333333,"avgChangeRate":0.002978},{"month":6,"riseRate":0.666667,"avgChangeRate":0.011102},{"month":7,"riseRate":0.666667,"avgChangeRate":0.009468},{"month":8,"riseRate":0.666667,"avgChangeRate":0.011194},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.002421},{"month":10,"riseRate":0.666667,"avgChangeRate":0.00649},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.002162},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.003597}],"exchange":"NYSE","name":"Prospect Capital Corp","nameEN":"Prospect Capital Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prospect Capital Corp(PBC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prospect Capital Corp,PBC,Prospect Capital Corp股票,Prospect Capital Corp股票老虎,Prospect Capital Corp股票老虎国际,Prospect Capital Corp行情,Prospect Capital Corp股票行情,Prospect Capital Corp股价,Prospect Capital Corp股市,Prospect Capital Corp股票价格,Prospect Capital Corp股票交易,Prospect Capital Corp股票购买,Prospect Capital Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prospect Capital Corp(PBC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}